Creo Medical Group

1. 30 Sep 26
   Unaudited interim results

   THIS ANNOUNCEMENT WAS DEEMED BY THE COMPANY TO CONTAIN INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATIONS (EU) NO.

   RNS 9797680 ↗
2. 05 Aug 26
   Holding(s) in Company

   RNS 9706594 ↗
3. 28 Jul 26
   H1-26 Trading Update

   Continued commercial momentum and a materially lower cost base

   RNS 9689895 ↗
4. 23 Jul 26
   MicroBlate™ Flex exceeds 100 clinical cases

   MicroBlate™ Flex exceeds 100 clinical cases as adoption builds

   RNS 9683040 ↗
5. 06 Jul 26
   Award of Shares under Share Incentive Plan

   Award of Shares under Share Incentive Plan and Director Dealings

   RNS 9654429 ↗
6. 29 Jun 26
   Result of AGM

   RNS 9641795 ↗
7. 29 Jun 26
   AGM Statement

   Creo Medical Group plc (AIM: CREO), the medical device company focused on the emerging field of minimally invasive surgical endoscopy for pre-cancer and cancer patients, provides an update to shareholders ahead of its Annual General Meeting ("AGM") being...

   RNS 9640289 ↗
8. 23 Jun 26
   Appointment of Nominated Adviser /Corporate Broker

   Creo Medical Group plc (AIM: CREO), the medical device company focused on the emerging field of minimally invasive surgical endoscopy for pre-cancer and cancer patients, announces the appointment of Shore Capital and Corporate Limited as its Nominated...

   RNS 9630755 ↗
9. 04 Jun 26
   Posting of 2025 Annual Report and Notice of AGM

   RNS 9600712 ↗
10. 28 May 26
    Holding(s) in Company

    RNS 9590499 ↗
11. 22 May 26
    Result of Placing

    The Issue Price represents a premium of approximately 31.9 per cent. to the closing middle market price of 11.4 pence per Existing Ordinary Share on 21 May 2026, being the latest practicable date prior to the publication of the Launch Announcement.

    RNS 9582454 ↗
12. 22 May 26
    Proposed Placing to raise approximately £5.5m

    Creo Medical Group plc (AIM:CREO), the medical device company focused on the emerging field of minimally invasive surgical endoscopy for pre-cancer and cancer patients (the "Company" or "Creo" and, together with its subsidiary undertakings, the "Group"),...

    RNS 9581458 ↗
13. 22 May 26
    FY25 Final Results

    Strong financial and operational delivery, in-line with market expectations

    RNS 9581457 ↗
14. 22 May 26
    Proposed Sale of 49% Interest in Creo Medical SL Disposal agreed

    THIS ANNOUNCEMENT WAS DEEMED BY THE COMPANY TO CONTAIN INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATIONS (EU) NO.

    RNS 9581352 ↗
15. 07 May 26
    MicroBlate™ Fine commercial update

    Creo Medical accelerates US clinical adoption and commercial rollout of MicroBlate Fine

    RNS 9556008 ↗
16. 05 May 26
    SpydrBlade™ Flex used in novel BEAM procedures

    Creo Medical's SpydrBlade™ Flex used in novel bariatric endoscopic technique

    RNS 9551036 ↗
17. 30 Apr 26
    KOL presentations on Creo Core Products at DDW

    KOL presentations on Creo Core Products at DDW

    RNS 9545372 ↗
18. 29 Apr 26
    UK private hospital use Speedboat for cancer case

    First UK private hospital use Speedboat for colorectal cancer case

    RNS 9542941 ↗
19. 22 Apr 26
    Positive Q1 trading update

    Strong trading momentum continues with 60% year-on-year revenue growth in Q1

    RNS 9531506 ↗
20. 16 Apr 26
    Disposal and outsourcing of manufacturing Disposal agreed

    Sale of manufacturing business to further reduce operating costs and improve margins

    RNS 9522683 ↗
21. 24 Feb 26
    Appointment of Joint Corporate Broker

    Creo Medical Group plc (AIM: CREO), the medical device company focused on the emerging field of minimally invasive surgical endoscopy for pre-cancer and cancer patients, announces the appointment of Shore Capital Stockbrokers Limited ("Shore Capital") as...

    RNS 9443510 ↗
22. 20 Jan 26
    FY25 Trading Update

    A year of strong financial and operational delivery

    RNS 9367662 ↗
23. 14 Jan 26
    Award of Shares under Share Incentive Plan

    Award of Shares under Share Incentive Plan and Director Dealings

    RNS 9351740 ↗
24. 27 Oct 25
    Notice of Capital Markets Day

    Creo Medical Group plc (AIM: CREO), the medical device company focused on the emerging field of minimally invasive surgical endoscopy for pre-cancer and cancer patients, announces that, further to the announcement on 7 October 2025, the Company will be...

    RNS 9194961 ↗
25. 07 Oct 25
    Capital Markets Day update

    CMD to be rearranged to allow clinician case using Creo products to be completed

    RNS 9155761 ↗

Source: Investegate RNS archive. Quotes are short extracts. Not investment advice.